Provided by Tiger Trade Technology Pte. Ltd.

Marten Transport

14.49
-0.1800-1.23%
Post-market: 14.490.00000.00%16:15 EDT
Volume:326.07K
Turnover:4.74M
Market Cap:1.18B
PE:96.59
High:14.77
Open:14.74
Low:14.48
Close:14.67
52wk High:18.48
52wk Low:9.35
Shares:81.52M
Float Shares:57.55M
Volume Ratio:0.77
T/O Rate:0.57%
Dividend:0.24
Dividend Rate:1.66%
EPS(TTM):0.1500
EPS(LYR):0.2100
ROE:1.65%
ROA:0.48%
PB:1.54
PE(LYR):69.00

Loading ...

May 07, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 26, 2021

Major Issues Report

8-K - Current report
Nov 18, 2020

Major Issues Report

8-K - Current report
Nov 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 15, 2020

Major Issues Report

8-K - Current report
Aug 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 16, 2020

Major Issues Report

8-K - Current report
May 11, 2020

Major Issues Report

Current report, items 5.02, 5.07, and 9.01
May 08, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 16, 2020

Major Issues Report

8-K - Current report
Feb 28, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 23, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Dec 23, 2019

Major Issues Report

Current report, item 5.02